A Spanish study of 310 girls has linked higher urinary levels of bisphenol A (BPA) and benzophenones to a greater likelihood of precocious puberty or early breast development, sharpening concern about hormone-disrupting chemicals still found around food packaging, plastics, cosmetics, sunscreens and personal-care products.
What the Spanish Study Actually Measured
The new findings come from a University of Granada study published in the European Journal of Pediatrics. Researchers analyzed urine samples from 182 girls aged 4 to 8 who had been diagnosed with precocious puberty, premature thelarche or related early-development conditions, then compared them with 128 girls without those diagnoses.
The headline number is striking, but it needs to be read carefully. The researchers found that BPA was associated with a 44% higher risk of showing any sign of early puberty for every twofold increase in urinary BPA levels. For diagnosed precocious puberty, the reported increase was 69%; for premature thelarche, it was 29%. Benzophenones, a class of ultraviolet filters used in some consumer products, were linked to roughly a threefold higher risk of early puberty.
That does not mean a single product, bottle or sunscreen causes early puberty in a child. It means the biological signal is becoming harder to dismiss: when researchers look at children with higher measured exposure to certain endocrine-disrupting chemicals, they are finding patterns that line up with earlier activation of puberty-related development.
| Measured factor | What the sources say | Why it matters |
|---|---|---|
| BPA | 44% higher risk of any early puberty sign for each twofold urinary increase. | BPA remains a useful marker for exposure to plastics and resin-related contaminants. |
| Benzophenones | Higher concentrations were linked to about a threefold increased risk. | These ultraviolet filters connect the puberty discussion to cosmetics and personal-care exposure, not only food packaging. |
| Combined phenols and metals | The mixture was associated with a 20% higher risk, with BPA the largest contributor. | Children are not exposed chemical by chemical; real life is a mixture. |
Why Everyday Exposure Is the Hard Part
Endocrine disruptors matter because they can mimic, block or interfere with hormones. Puberty is not switched on by one organ acting alone; it depends on a cascade involving the brain, pituitary gland and gonads. That is why researchers pay attention to chemicals with estrogen-like activity, including BPA and benzophenones, even when any one study stops short of proving direct causation.
The NIH has also highlighted research into environmental chemicals that may help activate pathways involved in early puberty. In that work, scientists screened thousands of compounds against human cell systems tied to puberty signaling. The point is not panic; it is that the science is moving from broad suspicion toward more specific biological pathways.
For families, the uncomfortable part is how ordinary the exposure routes are. The University of Granada release lists plastics, food packaging, cosmetics and personal-care products. Reporting on children’s product exposure has also pointed to lotions, soaps, sunscreen and hair-care items as possible sources of hormone-disrupting compounds. This is not an exotic industrial story. It is bathroom-shelf, lunchbox and packaging-drawer territory.
Earlier Puberty Is a Signal, Not a Simple Diagnosis
Doctors have been watching the timing of puberty shift for years. Hospiten notes that European data from the late 1970s to 2013 suggest puberty has advanced by about three months per decade, especially in girls. A separate international study covered by EL PAIS reported that thelarche, or breast budding, has been arriving earlier across generations.
That trend does not turn every early change into an emergency. Clinical context matters. In girls, the first sign of puberty is usually breast budding; in boys, doctors look at testicular volume. Puberty before age 8 in girls or before age 9 in boys is generally the threshold for medical evaluation. The better reading is neither alarm nor dismissal: earlier development is a signal that deserves attention, especially when it appears alongside rapid growth, emotional distress or other symptoms.
The Obesity and Environment Overlap
One reason the story is medically difficult is that chemical exposure is only one piece of the puberty puzzle. Hospiten points to obesity as a major factor because fat tissue is hormonally active and can contribute to earlier activation of puberty-related mechanisms. Sleep disruption, stress and higher screen use after the COVID-19 pandemic have also been discussed as part of the broader trend.
That overlap is exactly why the UGR findings are important. If earlier puberty were only about body weight or only about genetics, the policy answer would be narrower. But the emerging picture is messier: children are growing up inside a changed environment of diets, stress, consumer chemicals and product routines. The public-health question is not which single factor wins the blame contest. It is which exposures can be reduced without creating new burdens for families.
Regulation Is Moving, But Not Fast Enough
The European Union banned BPA in food-contact materials in January 2025, a major step that recognizes the risk profile of the compound. But the UGR researchers argue that restrictions on food packaging do not end the exposure story. BPA and related compounds can still appear through other consumer pathways, and children are a more vulnerable population because puberty depends on precise hormonal timing.
There is no certainty that current levels [of BPA] are still safe for children.
Professor Carmen Freire, University of Granada
The practical takeaway is not to empty the house overnight. It is to make the easy reductions first: avoid heating food in plastic, prefer glass or stainless steel for hot foods and drinks, reduce reliance on canned or ultra-processed foods where practical, and choose simpler fragrance-free personal-care products for children when there is no clear need for heavier formulations. None of those steps treats precocious puberty, and none replaces a pediatric evaluation. They are low-regret moves in a world where the evidence is no longer vague.
The strongest lesson from this study is also the most inconvenient one for regulators: child development is too sensitive for chemical safety to be judged only after exposures are already everywhere. The science is still developing, but the direction of travel is clear. Earlier puberty is not just a private family concern. It is a product-safety, environmental-health and childhood-development story converging in plain sight.
Find more reporting in our Health section.